AUS
NZ
UK
CA
USA
IND
Highlights
- ASX dips slightly as market navigates geopolitical tensions.
- Lithium and energy stocks face pullback after recent rallies.
- Key updates from companies including Chariot Corporation and Lumos Diagnostics.
The ASX saw a slight decline of 0.04% this morning as traders remain cautious amid ongoing tensions in the Middle East. Market activity has been relatively quiet, with no sector moving more than 1% aside from real estate.
Global markets also saw minimal movement overnight, with major indexes rising less than 0.1%. Energy stocks on the ASX retreated after yesterday’s rally, which followed a 5% surge in oil prices. The situation in the Middle East, particularly following recent strikes by Iran on Israel, has left traders uncertain about potential retaliatory responses and their impact on global markets.
Lithium Stocks Face Pressure
One of the biggest movers in today’s session was Pilbara Minerals (ASX:PLS), which fell 5% after reports surfaced about a $270 million block of shares being sold. This affected other lithium-related stocks such as MinRes (ASX:MIN) and IGO (ASX:IGO), which saw declines of over 1%.
In other lithium news, Chariot Corporation (ASX:CC9) revised its strategy for the Black Mountain Project in Wyoming. The company is now focusing on establishing a pilot mine to produce spodumene concentrate, aiming to capitalize on the growing lithium supply deficit in the US market. This shift in strategy is expected to offer more flexibility with lower upfront costs and could eventually lead to larger-scale mining operations.
Key Corporate Updates
Several key corporate announcements were made, including Westpac (ASX:WBC) confirming the sale of its auto finance loans to Resimac Group (ASX:RMC) for up to $1.6 billion. This transaction marks Westpac’s full exit from the auto finance sector, following a partial sale in 2021.
In healthcare, Lumos Diagnostics (ASX:LDX) received a significant funding boost of nearly US$3 million from the US Biomedical Advanced Research and Development Authority (BARDA) to support its FebriDx test. The funding will go towards a CLIA-waiver clinical study and FDA submission, aiming to expand the use of FebriDx in various outpatient settings.
Meanwhile, Golden Mile Resources (ASX:G88) announced further positive results from its Pearl Copper Project in Arizona, reporting visible copper and strong polymetallic potential, including copper values up to 13.4%.
As the ASX navigates global tensions and key sector adjustments, companies like Chariot Corporation and Lumos Diagnostics are pressing ahead with significant projects and strategies, despite broader market volatility. These developments show a diverse range of activities across the energy, healthcare, and resource sectors.
